CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.

Vedeld HM, Merok M, Jeanmougin M, Danielsen SA, Honne H, Presthus GK, Svindland A, Sjo OH, Hektoen M, Eknaes M, Nesbakken A, Lothe RA, Lind GE.

Int J Cancer. 2017 May 20. [Epub ahead of print]

PMID: 28542846

Published May 29, 2017 8:33 AM - Last modified May 29, 2017 8:33 AM